Overview
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Status:
Enrolling by invitation
Enrolling by invitation
Trial end date:
2025-05-26
2025-05-26
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AbbVieTreatments:
Venetoclax
Criteria
Inclusion Criteria:- Subject has been enrolled and dosed in an ongoing venetoclax study and continues to
tolerate and derive benefit from the study drug.
- Male subject agrees to refrain from sperm donation.
- Female subjects must not be pregnant or breastfeeding.
Exclusion Criteria:
- None.